These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30008476)

  • 1. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients.
    Calsina B; Currás-Freixes M; Buffet A; Pons T; Contreras L; Letón R; Comino-Méndez I; Remacha L; Calatayud M; Obispo B; Martin A; Cohen R; Richter S; Balmaña J; Korpershoek E; Rapizzi E; Deutschbein T; Vroonen L; Favier J; de Krijger RR; Fassnacht M; Beuschlein F; Timmers HJ; Eisenhofer G; Mannelli M; Pacak K; Satrústegui J; Rodríguez-Antona C; Amar L; Cascón A; Dölker N; Gimenez-Roqueplo AP; Robledo M
    Genet Med; 2018 Dec; 20(12):1652-1662. PubMed ID: 30008476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
    Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.
    Buffet A; Zhang J; Rebel H; Corssmit EPM; Jansen JC; Hensen EF; Bovée JVMG; Morini A; Gimenez-Roqueplo AP; Hes FJ; Devilee P; Favier J; Bayley JP
    J Clin Endocrinol Metab; 2021 Jan; 106(2):459-471. PubMed ID: 33180916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Exome Sequencing Identifies Novel Genetic Alterations in Patients with Pheochromocytoma/Paraganglioma.
    Seo SH; Kim JH; Kim MJ; Cho SI; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    Endocrinol Metab (Seoul); 2020 Dec; 35(4):909-917. PubMed ID: 33397043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study.
    Ma X; Li M; Tong A; Wang F; Cui Y; Zhang X; Zhang Y; Chen S; Li Y
    Front Endocrinol (Lausanne); 2020; 11():574662. PubMed ID: 33362715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular markers guide the genetics of pheochromocytoma and paraganglioma.
    Cascón A; Robledo M
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189141. PubMed ID: 38908536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Bayley JP; Bausch B; Jansen JC; Hensen EF; van der Tuin K; Corssmit EP; Devilee P; Neumann HP
    J Med Genet; 2023 Jan; 60(1):25-32. PubMed ID: 34750193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International initiative for a curated
    Ben Aim L; Maher ER; Cascon A; Barlier A; Giraud S; Ercolino T; Pigny P; Clifton-Bligh RJ; Mirebeau-Prunier D; Mohamed A; Favier J; Gimenez-Roqueplo AP; Schiavi F; Toledo RA; Dahia PL; Robledo M; Bayley JP; Burnichon N
    J Med Genet; 2022 Aug; 59(8):785-792. PubMed ID: 34452955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
    Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
    J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.
    Remacha L; Pirman D; Mahoney CE; Coloma J; Calsina B; Currás-Freixes M; Letón R; Torres-Pérez R; Richter S; Pita G; Herráez B; Cianchetta G; Honrado E; Maestre L; Urioste M; Aller J; García-Uriarte Ó; Gálvez MÁ; Luque RM; Lahera M; Moreno-Rengel C; Eisenhofer G; Montero-Conde C; Rodríguez-Antona C; Llorca Ó; Smolen GA; Robledo M; Cascón A
    Am J Hum Genet; 2019 Apr; 104(4):651-664. PubMed ID: 30929736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.
    Hadrava Vanova K; Pang Y; Krobova L; Kraus M; Nahacka Z; Boukalova S; Pack SD; Zobalova R; Zhu J; Huynh TT; Jochmanova I; Uher O; Hubackova S; Dvorakova S; Garrett TJ; Ghayee HK; Wu X; Schuster B; Knapp PE; Frysak Z; Hartmann I; Nilubol N; Cerny J; Taieb D; Rohlena J; Neuzil J; Yang C; Pacak K
    J Natl Cancer Inst; 2022 Jan; 114(1):130-138. PubMed ID: 34415331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
    Bancel LP; Masso V; Dessein AF; Aubert S; Leteurtre E; Coppin L; Odou MF; Cao CD; Cardot-Bauters C; Pigny P
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2343-2352. PubMed ID: 36848172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
    Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of metastatic pheochromocytoma and paraganglioma in
    Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
    J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPAS1-related pheochromocytoma/paraganglioma.
    Alzahrani AS; Alswailem M; Buffet A; Alghamdi B; Alobaid L; Alsagheir O; Al-Hindi H; Pacak K
    Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38767322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma.
    Kim JH; Kim MJ; Kong SH; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    J Med Genet; 2022 Jan; 59(1):56-64. PubMed ID: 33219105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic predisposition to pheochromocytoma and paraganglioma: 21 years of experience in the field.
    Cardot-Bauters C; Vantyghem MC; Do Cao C; Desailloud R; Joubert M; Coppin L; Odou MF; Pigny P
    Ann Endocrinol (Paris); 2024 Jul; 85(4):276-283. PubMed ID: 38815921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.